Saatheeyavaane Bhuvanendran
Overview
Explore the profile of Saatheeyavaane Bhuvanendran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phon B, Chelliah S, Osman D, Bhuvanendran S, Radhakrishnan A, Kamarudin M
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861164
: The multiple drug-resistant phenomenon has long since plagued the effectiveness of various chemotherapies used in the treatment of patients with glioblastoma (GBM), which is still incurable to this day....
2.
Morgan N, Ramdas P, Bhuvanendran S, Radhakrishnan A
Biomed Res Int
. 2024 Oct;
2024:5512422.
PMID: 39416707
Cancer is a disease resulting from uncontrolled cell division, which significantly contributes to human mortality rates. An alternative approach to cancer treatment, such as cancer immunotherapy, is needed as the...
3.
Morgan N, Magalingam K, Radhakrishnan A, Arumugam M, Jamil A, Bhuvanendran S
Skin Health Dis
. 2024 Oct;
4(5):e448.
PMID: 39355739
The skin is the largest organ in the integumentary system, protecting against various external threats, including ultraviolet exposure, heat, infections, dehydration and mechanical injuries. Skin disorders can arise from various...
4.
Guo H, Lee Z, Magalingam K, Radhakrishnan A, Bhuvanendran S
Neurochem Int
. 2024 Sep;
180:105857.
PMID: 39293662
Parkinson's disease (PD) is the second most common neurodegenerative disease, and it has affected the living quality of elderly people significantly. PD is characterised by the accumulation of α-Synuclein and...
5.
Mathew A, Bhuvanendran S, Nair R, Radhakrishnan A
F1000Res
. 2024 Sep;
12:338.
PMID: 39291146
A major cause of death in the elderly worldwide is attributed to neurodegenerative diseases, such as AD (Alzheimer's disease), PD (Parkinson's disease), ALS (Amyotrophic lateral sclerosis), FRDA (Friedreich's ataxia), VaD...
6.
Khalid A, Zaidan T, Bhuvanendran S, Magalingam K, Mohamedahmed S, Ramdas P, et al.
Nutr Rev
. 2024 Aug;
83(3):e1295-e1310.
PMID: 39181121
Colorectal cancer (CRC) is a growing concern all over the world. There has been a concerted effort to identify natural bioactive compounds that can be used to prevent or overcome...
7.
Zainuddin M, Bhuvanendran S, Radhakrishnan A, Azman A
J Alzheimers Dis Rep
. 2023 Dec;
7(1):1335-1350.
PMID: 38143777
Background: Alzheimer's disease (AD) is a neurodegenerative disease that is characterized as rapid and progressive cognitive decline affecting 26 million people worldwide. Although immunotherapies are ideal, its clinical safety and...
8.
Phon B, Bhuvanendran S, Ayub Q, Radhakrishnan A, Kamarudin M
Biology (Basel)
. 2023 May;
12(5).
PMID: 37237462
A paradigm shift in preclinical evaluations of new anticancer GBM drugs should occur in favour of 3D cultures. This study leveraged the vast genomic data banks to investigate the suitability...
9.
Bhuvanendran S, Paudel Y, Kumari Y, Othman I, Shaikh M
Curr Res Neurobiol
. 2022 Dec;
3:100032.
PMID: 36518345
Embelin is a neuroprotective compound with therapeutic benefit against experimental Alzheimer's disease (AD)-like condition. In the quest of untangling the underlying mechanism behind the neuroprotective effect of Embelin in AD,...
10.
Magalingam K, Ramdas P, Somanath S, Selvaduray K, Bhuvanendran S, Radhakrishnan A
Nutrients
. 2022 Nov;
14(21).
PMID: 36364894
Tocotrienol-rich fraction (TRF), a palm oil-derived vitamin E fraction, is reported to possess potent neuroprotective effects. However, the modulation of proteomes in differentiated human neuroblastoma SH-SY5Y cells (diff-neural cells) by...